Highlights
-
Two ERC-funded projects to search for tumours’ weaknesses
Human Technopole has once again been awarded by Europe’s prestigious public body for funding of scientific research conducted within the European Union, the European Research Council (ERC), for two projects on the origin of tumours, their evolution and the development of resistance to therapies. The two studies could contribute to the identification of new anti-cancer targeted […]
-
COVID-19: How SARS‑CoV‑2 Enters Human Cells
A study by the University of Padua and Human Technopole, together with the University of Milan and the European Institute of Oncology, published in Cell Reports Medicine, reveals that SARS-CoV-2, the virus that causes COVID-19, binds the RAGE receptor present on the surface of specific human immune cells to penetrate them and pathologically alter their function. This study also shows how the involvement of RAGE, previously known only in the context of other pathophysiological conditions, such as obesity and diabetes, is implicated in the degree of severity with which COVID-19 can manifest.
-
Italy joins the iCARE4CVD consortium
The Human Technopole and Mario Negri institute for Pharmacological Research are among 33 leading international partners who have joined forces to better understand cardiovascular diseases and optimise future prevention and treatment.
-
Welcome to our new Director Marino Zerial
On 1 September 2023 the Human Technopole community warmly welcomed Marino Zerial as he officially took office as the institute’s new Director.
-
Future Trends in Translational Medicine
Human Technopole’s Centre for Innovation and Technology Transfer (CITT) and Nature Italy are organizing – on 26 and 27 October 2023 – a conference aimed at investigating the new frontiers of research in the life sciences.
Research at HT


Improving human health and well-being is the ultimate goal of Human Technopole. We need to prevent and cure diseases to allow people of all ages to not only live longer, but also live better.
Discover more about our:
Thanks to a comprehensive and interdisciplinary approach to the study of human biology, HT’s research aims to understand the mechanisms underlying various diseases, exploiting the technological advances of the last decade and the enormous amount of biological, clinical and socio-economic data currently available to improve the national healthcare system and the quality of life of all citizens.
Human Technopole’s research is based on five interdisciplinary research areas: Genomics, Neurogenomics, Structural Biology, Computational Biology and Health Data Science.
Starting from early 2024, Human Technopole will be opening the first National Facilities available to the national scientific community to carry out top-level research in their respective fields.
External Training
Work with us


We offer the opportunity to be part of a new, dynamic research institute promoting a highly collaborative and international working environment.
We aim to attract the best resources in each field with a selection based on merit and transparency as we believe that highly diverse teams produce the best and most innovative results.
If you are a passionate person who likes to seize great challenges, consider applying for one of our scientific or administrative vacancies.